Status | Study |
Not yet recruiting |
Study Name: Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis Condition: Coccidioidomycosis Date: 2016-09-14 Interventions: Drug: Sertraline 400 mg/day sertraline |
Recruiting |
Study Name: Lyon Cohort of Maternal and Congenital Toxoplasma Infections Condition: Toxoplasmosis, Congenital Date: 2016-09-06 |
Not yet recruiting |
Study Name: Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis Condition: Toxoplasmosis Infection Genotype II Ocular Toxoplasmosis W Date: 2016-08-08 Interventions: Biological: seropositive for Toxoplasma gondii blood sample |
Completed |
Study Name: Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis Condition: Subjects Clinically Suspected an Active Source of Toxoplasmosis Chorioretinitis Infection Date: 2016-07-21 Interventions: Other: Fluorescein angiography Other: Dila |
Recruiting |
Study Name: Early Fluconazole Treatment for Coccidiodomycosis Pneumonia Condition: Coccidioidomycosis Date: 2016-01-15 Interventions: Drug: Fluconazole Fluconazole |
Recruiting |
Study Name: Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis Condition: Coccidioidomycosis Date: 2014-07-12 |
Active, not recruiting |
Study Name: Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia Condition: Toxoplasmosis Schizophrenia Date: 2013-06-21 Interventions: Drug: Sodium Valproate treatment |
Completed |
Study Name: Antiretroviral Drug Interaction Study in Volunteers With HIV Condition: HIV PCP Toxoplasmosis Date: 2011-11-22 Interventions: Drug: Atovaquone 750 mg twice daily Drug: |
Completed |
Study Name: Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis Condition: Ocular Toxoplasmosis Date: 2011-10-06 Interventions: Drug: Trimethoprim-Sulfamethoxazole Sulfamethoxazole 800mg + Trimethoprim 160mg / tablet. In treatment o |
Recruiting |
Study Name: Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis Condition: Congenital Toxoplasmosis Date: 2010-09-15 Interventions: Procedure: reducing treatment to 3 months |